Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-23

Clinical Trial Update: OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator

View source ↗

Summary

A completed French observational study (OPERA) evaluating outcomes in patients implanted with Guidant PRIZM or Vitality implantable defibrillators.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIZM Defibrillator
  • Vitality Defibrillator

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ventricular Tachycardia, Ventricular Fibrillation | Status: COMPLETED